Opening Bell Analysts Research Calls for Thursday, March 16

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Opening Bell Analysts Research Calls for Thursday, March 16

© Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Research calls posted earlier this morning are available here

Upgrades:

> Alamo Group (ALG) upgraded to Buy from Neutral at DA Davidson; tgt raised to $196

> Block (SQ) upgraded to Buy from Neutral at Mizuho; tgt raised to $93

> Deutsche Boerse (DBOEY) upgraded to Outperform from Neutral at Credit Suisse

> HF Sinclair (DINO) upgraded to Overweight from Equal Weight at Wells Fargo; tgt $55

> LexinFintech (LX) upgraded to Buy from Accumulate at CLSA; tgt $3.45

> On (ONON) upgraded to Outperform from Neutral at Wedbush; tgt raised to $25

> Progressive (PGR) upgraded to Overweight from Underweight at Wells Fargo; tgt raised to $158

> TPI Composites (TPIC) upgraded to Buy from Neutral at Guggenheim; tgt $22

> UiPath (PATH) upgraded to Buy from Hold at Canaccord Genuity; tgt raised to $19

> Under Armour (UAA) upgraded to Buy from Hold at Williams Trading; tgt $11

Downgrades:

> Halozyme Therapeutics (HALO) downgraded to Market Perform from Outperform at SVB Securities; tgt $42

> Kezar Life Sciences (KZR) downgraded to Mkt Perform from Outperform at William Blair

> LivePerson (LPSN) downgraded to Hold from Buy at Craig Hallum; tgt lowered to $6

> Man Group (MNGPF) downgraded to Neutral from Outperform at Exane BNP Paribas

> Millicom International Cellular (TIGO) downgraded to Neutral from Overweight at JP Morgan

> Mytheresa (MYTE) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $7

> Olaplex (OLPX) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $4.50

Others:

> Cerevel Therapeutics (CERE) resumed with a Hold at Berenberg; tgt $22

> Inc. (EHAB) initiated with a Neutral at Goldman; tgt $15

> Global Net Lease (GNL) initiated with an Underperform at Exane BNP Paribas; tgt $13

> Intuit (INTU) initiated with a Neutral at UBS; tgt $430

> Safehold (SAFE) initiated with an Outperform at Exane BNP Paribas

> Samsara (IOT) initiated with a Neutral at Piper Sandler; tgt $21

> StoneCo (STNE) removed from Tactical Outperform List at Evercore ISI

> Theseus Pharmaceuticals (THRX) initiated with a Buy at Stifel; tgt $24

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618